Production cell line

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8962277
SERIAL NO

13808380

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention refers to a method of producing a recombinant polypeptide of interest (POI) in a cell culture, comprising genetically engineering a eukaryotic cell line—to specifically cause prolongation of the G2+M cell cycle phase in a pre-culture phase, and—to produce the POI in a producing phase following the pre-culture phase, a high producer cell line and cell culture as well as a method of increasing the yield of a recombinant POI production in a cell culture.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
LONZA LTDLONZASTRASSE VISP 3930

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Dragosits, Martin Vienna, AT 1 0
Gasser, Brigitte Vienna, AT 22 28
Mattanovich, Diethard Vienna, AT 30 40
Maurer, Michael Vienna, AT 55 622
Sauer, Michael Vienna, AT 217 6782

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 24, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00